BIB

Ultra Nasdaq Biotechnology

BIB seeks daily investment results, before fees and expenses, that correspond to two times (2x) the daily performance of the Nasdaq Biotechnology® Index.

How to Buy
Why BIB?
Target Magnified Returns

BIB is the only ETF that targets 2x the daily returns of the Biotechnology industry.

Efficient

BIB offers 2x exposure with less cash.

Convenience

Buy and sell leveraged exposure via a single ticker in a brokerage account.

This ProShares ETF seeks daily investment results that correspond, before fees and expenses, to 2x the daily performance of its underlying benchmark (the “Daily Target”).

While the Fund has a daily investment objective, you may hold Fund shares for longer than one day if you believe it is consistent with your goals and risk tolerance. For any holding period other than a day, your return may be higher or lower than the Daily Target. These differences may be significant. Smaller index gains/losses and higher index volatility contribute to returns worse than the Daily Target. Larger index gains/losses and lower index volatility contribute to returns better than the Daily Target.

The more extreme these factors are, the more they occur together, and the longer your holding period while these factors apply, the more your return will tend to deviate. Investors should consider periodically monitoring their geared fund investments in light of their goals and risk tolerance.

Performance

30 Day Daily Return

Chart is updated nightly to reflect the more recent of the previous day's market closing price or the closing price on the day the fund was last traded.

Total Return

Fund 1m 3m 6m YTD 1Y 3Y 5Y 10Y Since Inception Inception Date
BIB NAV -7.55% 2.21% 37.13% 2.21% 70.94% 15.59% 0.06% 7.43% 16.31% 04/07/2010
BIB Market Price -7.52% 2.18% 37.06% 2.18% 70.63% 15.62% 0.04% 7.44% 16.31% 04/07/2010

The performance quoted represents past performance and does not guarantee future results. Investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than the original cost. Shares are bought and sold at market price (not NAV) and are not individually redeemed from the fund. Market price returns are based upon the midpoint of the bid/ask spread at 4:00 p.m. ET (when NAV is normally determined for most funds) and do not represent the returns you would receive if you traded shares at other times. Your brokerage commissions will reduce returns. Current performance may be lower or higher than the performance quoted. For standardized returns and performance data current to the most recent month end, see above.

About the Fund

Snapshot
  • Ticker
    BIB
  • Intraday Ticker
    BIB.IV
  • CUSIP
    74347R214
  • Inception Date
    4/7/10
  • Net Assets
    $84,456,704
  • Gross Expense Ratio
    1.19%
  • Net Expense Ratio
    0.95%
  • NAV Calculation Time
    4:00 p.m. ET
  • Distributions
    Quarterly
  • Options Available
    Yes
Price
as of 4/15/2026
  • NAV
    $87.98
  • NAV Change
    $+0.29 up caret
  • Market Price
    $87.97
  • Market Price Change
    $+0.33 up caret
  • Trading Volume (M)
    6,299
  • View Premium / Discount
Snapshot
  • Ticker
    BIB
  • Intraday Ticker
    BIB.IV
  • CUSIP
    74347R214
  • Inception Date
    4/7/10
  • Net Assets
    $84,456,704
  • Gross Expense Ratio
    1.19%
  • Net Expense Ratio
    0.95%
  • NAV Calculation Time
    4:00 p.m. ET
  • Distributions
    Quarterly
  • Options Available
    Yes
Price
as of 4/15/2026
  • NAV
    $87.98
  • NAV Change
    $+0.29 up caret
  • Market Price
    $87.97
  • Market Price Change
    $+0.33 up caret
  • Trading Volume (M)
    6,299
  • View Premium / Discount

Expenses with Contractual Waiver through September 30, 2026. Without the fee waiver performance would likely be lower.

Exposures

Index as of 3/31/2026

Holdings

as of 4/14/2026

Exposure Weight Ticker Description Exposure Value
(Notional + GL)
Market Value Shares/Contracts SEDOL Number
4.93% GILD GILEAD SCIENCES INC -- $4,148,471.65 29,537 2369174
4.73% AMGN AMGEN INC -- $3,978,018.25 11,335 2023607
4.67% VRTX VERTEX PHARMACEUTICALS INC -- $3,933,655.12 8,854 2931034
3.99% REGN REGENERON PHARMACEUTICALS -- $3,354,464.40 4,440 2730190
2.29% ALNY ALNYLAM PHARMACEUTICALS INC -- $1,923,775.88 5,668 B00FWN1
1.68% INSM INSMED INC -- $1,413,734.40 9,216 2614487
1.48% RVMD REVOLUTION MEDICINES INC -- $1,245,468.72 8,472 BL71K91
1.33% BIIB BIOGEN INC -- $1,122,616.08 6,273 2455965
1.29% UTHR UNITED THERAPEUTICS CORP -- $1,083,605.42 1,873 2430412
1.19% ARGX ARGENX SE - ADR -- $1,003,960.20 1,212 BDVLM39
1.06% RPRX ROYALTY PHARMA PLC- CL A -- $894,187.12 18,316 BMVP7Y0
1.06% MRNA MODERNA INC -- $892,150.56 16,884 BGSXTS3
1.06% ROIV ROIVANT SCIENCES LTD -- $891,101.12 30,601 BMW4NZ9
1.01% ILMN ILLUMINA INC -- $852,032.16 6,538 2613990
0.99% INCY INCYTE CORP -- $831,244.21 8,509 2471950
0.82% SMMT SUMMIT THERAPEUTICS INC -- $691,177.50 33,150 BMTVQS7
0.81% VTRS VIATRIS INC -- $684,747.57 49,227 BMWS3X9
0.78% ASND ASCENDIS PHARMA A/S - ADR -- $657,329.04 2,631 BV9G6B8
0.77% BBIO BRIDGEBIO PHARMA INC -- $645,961.77 8,289 BK1KWG8
0.75% MEDP MEDPACE HOLDINGS INC -- $630,240.00 1,212 BDCBC61
0.67% NBIX NEUROCRINE BIOSCIENCES INC -- $561,436.52 4,292 2623911
0.64% IONS IONIS PHARMACEUTICALS INC -- $542,155.88 7,063 BDJ0LS6
0.63% JAZZ JAZZ PHARMACEUTICALS PLC -- $528,988.86 2,631 B4Q5ZN4
0.61% MDGL MADRIGAL PHARMACEUTICALS INC -- $515,540.18 982 BD59BS7
0.60% EXEL EXELIXIS INC -- $509,229.44 11,104 2576941
0.59% SNY SANOFI-ADR -- $498,457.32 10,463 2964557
0.58% GH GUARDANT HEALTH INC -- $484,358.40 5,606 BFXC911
0.57% BNTX BIONTECH SE-ADR -- $479,355.11 4,871 BK6H543
0.54% BMRN BIOMARIN PHARMACEUTICAL INC -- $456,129.81 8,223 2437071
0.50% ONC BEONE MEDICINES LTD-ADR -- $423,770.00 1,367 BYYWPW6
0.49% PRAX PRAXIS PRECISION MEDICINES I -- $409,227.60 1,191 BQ721R4
0.48% AXSM AXSOME THERAPEUTICS INC -- $402,801.66 2,187 BYZR4X4
0.47% ARWR ARROWHEAD PHARMACEUTICALS IN -- $399,406.41 5,989 BYQBFJ8
0.46% PCVX VAXCYTE INC -- $386,162.28 6,153 BKPVGH6
0.44% TEM TEMPUS AI INC-CL A -- $367,809.78 7,426 BSLSJJ0
0.42% CYTK CYTOKINETICS INC -- $349,399.10 5,266 BBBSBJ5
0.40% HALO HALOZYME THERAPEUTICS INC -- $339,646.26 5,046 2975098
0.40% KRYS KRYSTAL BIOTECH INC -- $338,040.00 1,252 BD6JX35
0.40% IBRX IMMUNITYBIO INC -- $334,073.20 43,957 BNSP0B8
0.39% ABVX ABIVAX SA-ADR -- $330,225.00 2,625 BLC89B2
0.39% NUVL NUVALENT INC-A -- $328,712.60 3,130 BMVBZD3
0.37% KYMR KYMERA THERAPEUTICS INC -- $313,538.99 3,489 BMPRZV5
0.34% PTGX PROTAGONIST THERAPEUTICS INC -- $285,780.88 2,729 BDCBCD8
0.31% PTCT PTC THERAPEUTICS INC -- $258,309.38 3,538 B17VCN9
0.30% RYTM RHYTHM PHARMACEUTICALS INC -- $254,857.60 2,920 BF2YWG4
0.30% COGT COGENT BIOSCIENCES INC -- $253,240.60 6,940 BLR6XK8
0.30% MIRM MIRUM PHARMACEUTICALS INC -- $249,905.10 2,579 BJDX8Y8
0.29% CAI CARIS LIFE SCIENCES INC -- $243,572.16 12,064 BT18HP9
0.29% CGON CG ONCOLOGY INC -- $242,880.80 3,610 BRBCSP4
0.29% ALKS ALKERMES PLC -- $241,323.75 7,125 B3P6D26
0.28% TERN TERNS PHARMACEUTICALS INC -- $239,535.96 4,547 BMDJ0C9
0.28% ERAS ERASCA INC -- $236,298.30 13,238 BNLYBF3
0.28% CRSP CRISPR THERAPEUTICS AG -- $233,353.44 4,104 BDHF4K6
0.27% IMVT IMMUNOVANT INC -- $231,091.20 8,704 BJRFSB7
0.27% APLS APELLIS PHARMACEUTICALS INC -- $223,286.10 5,466 BYTQ6X1
0.26% SRRK SCHOLAR ROCK HOLDING CORP -- $216,186.65 4,363 BFZQ0L8
0.26% SYRE SPYRE THERAPEUTICS INC -- $214,881.57 3,357 BQBBDY8
0.25% XENE XENON PHARMACEUTICALS INC -- $211,107.95 3,557 BRJ3GY4
0.25% APGE APOGEE THERAPEUTICS INC -- $207,373.68 2,344 BM9HHL5
0.24% CNTA CENTESSA PHARMACEUTICALS-ADR -- $202,463.26 5,114 BLB0YQ9
0.24% LGND LIGAND PHARMACEUTICALS -- $197,953.68 852 2501578
0.21% CRNX CRINETICS PHARMACEUTICALS IN -- $177,960.75 4,477 BDD19F8
0.21% GPCR STRUCTURE THERAPEUTICS INC -- $177,329.04 3,332 BQS9486
0.21% AMRX AMNEAL PHARMACEUTICALS INC -- $176,490.24 13,452 BFNF1D6
0.21% INDV INDIVIOR PHARMACEUTICALS INC -- $176,224.65 5,345 BTZRLN8
0.20% -- NEWAMSTERDAM PHARMA CO NV -- $169,238.16 4,914 BP8JSP4
0.20% TVTX TRAVERE THERAPEUTICS INC -- $166,160.72 3,944 BLFGJD5
0.19% ACAD ACADIA PHARMACEUTICALS INC -- $160,459.74 7,287 2713317
0.18% EWTX EDGEWISE THERAPEUTICS INC -- $152,038.60 4,585 BKY5JZ8
0.18% TWST TWIST BIOSCIENCE CORP -- $150,529.02 2,622 BGKG6G7
0.17% DYN DYNE THERAPEUTICS INC -- $139,422.78 7,038 BN15WD1
0.16% ORKA ORUKA THERAPEUTICS INC -- $138,747.14 2,069 BKVF0J2
0.16% TNGX TANGO THERAPEUTICS INC -- $138,537.48 5,758 BP2P6L0
0.16% DNLI DENALI THERAPEUTICS INC -- $136,684.80 6,780 BD2B4V0
0.16% VERA VERA THERAPEUTICS INC -- $135,342.36 3,051 BL55460
0.16% TARS TARSUS PHARMACEUTICALS INC -- $134,260.39 1,819 BMH5RL1
0.16% ARQT ARCUTIS BIOTHERAPEUTICS INC -- $132,926.82 5,298 BKX9VD3
0.16% BEAM BEAM THERAPEUTICS INC -- $131,986.80 4,356 BK6L288
0.15% TXG 10X GENOMICS INC-CLASS A -- $124,744.00 5,030 BKS3RS7
0.15% ALMS ALUMIS INC -- $123,743.34 5,406 BPLQG36
0.15% SUPN SUPERNUS PHARMACEUTICALS INC -- $122,819.61 2,451 B72ZBG4
0.14% IDYA IDEAYA BIOSCIENCES INC -- $121,474.25 3,755 BK0VHF6
0.14% KOD KODIAK SCIENCES INC -- $117,632.70 2,610 BFXC933
0.14% VCYT VERACYTE INC -- $116,585.70 3,399 BFTWZY0
0.14% IRON DISC MEDICINE INC -- $115,023.36 1,632 BMGJZJ8
0.14% ELVN ENLIVEN THERAPEUTICS INC -- $113,874.15 2,539 BMFD115
0.13% RLAY RELAY THERAPEUTICS INC -- $112,704.75 7,641 BN2R582
0.13% ADMA ADMA BIOLOGICS INC -- $106,819.67 10,183 B9NSBM2
0.12% BCRX BIOCRYST PHARMACEUTICALS INC -- $103,710.75 10,725 2100362
0.12% RARE ULTRAGENYX PHARMACEUTICAL IN -- $101,498.67 4,131 BJ62Z18
0.12% SRPT SAREPTA THERAPEUTICS INC -- $99,254.15 4,481 B8DPDT7
0.11% ADPT ADAPTIVE BIOTECHNOLOGIES -- $95,636.46 6,582 BJ5FZ74
0.11% DAWN DAY ONE BIOPHARMACEUTICALS I -- $94,788.82 4,417 BLB0YH0
0.11% DFTX DEFINIUM THERAPEUTICS INC -- $93,465.66 4,262 BV2DHY6
0.11% MLYS MINERALYS THERAPEUTICS INC -- $92,450.88 3,384 BP9N0G0
0.11% SNDX SYNDAX PHARMACEUTICALS INC -- $92,125.53 3,771 BN7Q7R7
0.11% KNSA KINIKSA PHARMACEUTICALS INTE -- $92,103.96 1,963 BRXB0C0
0.11% AUPH AURINIA PHARMACEUTICALS INC -- $91,341.88 5,684 BFWLC09
0.10% STOK STOKE THERAPEUTICS INC -- $87,534.26 2,441 BJQ05Z6
0.10% ZYME ZYMEWORKS INC -- $86,362.98 3,201 BPCQZY9
0.10% GRAL GRAIL INC -- $84,065.85 1,665 BSLSSX7
0.10% AGIO AGIOS PHARMACEUTICALS INC -- $83,383.20 2,504 BCBVTX1
0.10% ANAB ANAPTYSBIO INC -- $83,280.92 1,186 BDRW1L7
0.10% SION SIONNA THERAPEUTICS INC -- $82,703.00 1,910 BQKXDX4
0.10% OCUL OCULAR THERAPEUTIX INC -- $81,529.32 9,307 BNZB1X8
0.10% TYRA TYRA BIOSCIENCES INC -- $80,486.14 2,282 BMVNDH9
0.10% GMAB GENMAB A/S -SP ADR -- $80,002.18 2,753 BBC9WC7
0.09% AMLX AMYLYX PHARMACEUTICALS INC -- $79,473.24 4,697 BPCK358
0.09% RXRX RECURSION PHARMACEUTICALS-A -- $79,002.18 22,317 BM9FJ13
0.09% PHVS PHARVARIS NV -- $78,583.20 2,740 BMZ2X38
0.09% TRVI TREVI THERAPEUTICS INC -- $76,953.24 5,481 BJH9ZN0
0.09% INVA INNOVIVA INC -- $76,585.54 3,166 BDDXF67
0.09% VCEL VERICEL CORP -- $76,324.08 2,172 BSBMN89
0.09% ANIP ANI PHARMACEUTICALS INC -- $75,001.82 958 BCDWBX6
0.09% NTLA INTELLIA THERAPEUTICS INC -- $74,639.00 5,050 BYZM6C2
0.09% RAPP RAPPORT THERAPEUTICS INC -- $73,709.85 2,039 BR3T9B6
0.09% HRMY HARMONY BIOSCIENCES HOLDINGS -- $72,463.46 2,474 BKSGZN7
0.09% NRIX NURIX THERAPEUTICS INC -- $71,654.80 4,396 BMVLGP2
0.08% VIR VIR BIOTECHNOLOGY INC -- $67,525.95 6,719 BK4PZ38
0.08% LEGN LEGEND BIOTECH CORP-ADR -- $67,433.52 3,608 BMX9K07
0.08% ARDX ARDELYX INC -- $66,363.72 10,484 BN89V40
0.08% IOVA IOVANCE BIOTHERAPEUTICS INC -- $64,107.68 17,612 BF0DMK7
0.07% MBX MBX BIOSCIENCES INC -- $62,962.39 1,919 BQXJKH2
0.07% BCAX BICARA THERAPEUTICS INC -- $62,229.84 2,708 BQB42F1
0.07% PGEN PRECIGEN INC -- $60,213.42 15,129 BKM5C84
0.07% HROW HARROW INC -- $60,109.40 1,586 BHNDW86
0.07% ATAI ATAIBECKLEY INC -- $59,782.80 15,528 BWJDYK1
0.07% WVE WAVE LIFE SCIENCES LTD -- $59,482.11 8,049 BYZG9R0
0.07% IMCR IMMUNOCORE HOLDINGS PLC-ADR -- $59,387.06 1,874 BLCD809
0.07% NVAX NOVAVAX INC -- $58,427.96 6,964 BJDQXG4
0.07% GLUE MONTE ROSA THERAPEUTICS INC -- $57,067.50 3,261 BP7KZP7
0.07% MAZE MAZE THERAPEUTICS INC -- $56,937.76 2,057 BSRK699
0.07% OLMA OLEMA PHARMACEUTICALS INC -- $55,843.80 3,426 BMZ4LN0
0.07% TSHA TAYSHA GENE THERAPIES INC -- $55,154.10 11,710 BNC1BX1
0.07% NVCR NOVOCURE LTD -- $54,974.50 4,865 BYSS4X4
0.06% CRVS CORVUS PHARMACEUTICALS INC -- $53,863.00 3,532 BYP80F1
0.06% SVRA SAVARA INC -- $52,815.07 8,701 BYXGN81
0.06% PAHC PHIBRO ANIMAL HEALTH CORP-A -- $51,996.62 881 BL95N25
0.06% INBX INHIBRX BIOSCIENCES INC -- $51,660.99 621 BNSP8K3
0.06% EYPT EYEPOINT INC -- $50,749.26 3,539 BMGS7L1
0.06% ALVO ALVOTECH SA -- $49,850.66 14,122 BPNTJ34
0.06% ZBIO ZENAS BIOPHARMA INC -- $49,722.20 2,330 BQB42H3
0.06% AVBP ARRIVENT BIOPHARMA INC -- $48,812.24 1,766 BMGTLY5
0.06% ABCL ABCELLERA BIOLOGICS INC -- $48,737.12 12,962 BL53SR3
0.06% COLL COLLEGIUM PHARMACEUTICAL INC -- $48,399.12 1,358 BX7RSN3
0.06% GERN GERON CORP -- $48,308.61 27,293 2370381
0.05% SEPN SEPTERNA INC -- $46,160.69 1,913 BQNKXX2
0.05% QURE UNIQURE NV -- $45,527.76 2,664 BJFSR88
0.05% ORIC ORIC PHARMACEUTICALS INC -- $45,194.76 4,292 BKVDFF7
0.05% GHRS GH RESEARCH PLC -- $44,474.04 2,652 BP6C0S2
0.05% GRFS GRIFOLS SA-ADR -- $44,319.00 5,214 B8K7T65
0.05% KALV KALVISTA PHARMACEUTICALS INC -- $43,866.98 2,162 BD06CS0
0.05% XERS XERIS BIOPHARMA HOLDINGS INC -- $43,066.65 7,095 BLR7H87
0.05% PHAT PHATHOM PHARMACEUTICALS INC -- $42,672.56 3,368 BJLKVS6
0.05% URGN UROGEN PHARMA LTD -- $42,440.00 2,000 BZ7PJQ1
0.05% AMPH AMPHASTAR PHARMACEUTICALS IN -- $41,455.82 1,939 BNFWZS4
0.05% PCRX PACIRA BIOSCIENCES INC -- $41,063.75 1,729 B3X26D8
0.05% JANX JANUX THERAPEUTICS INC -- $39,654.48 2,602 BMFX8Y7
0.05% SANA SANA BIOTECHNOLOGY INC -- $39,630.24 11,388 BMFJJ97
0.05% XNCR XENCOR INC -- $39,243.87 3,137 BGCYWN8
0.05% MGTX MEIRAGTX HOLDINGS PLC -- $38,848.89 3,441 BFYQFJ2
0.05% FTRE FORTREA HOLDINGS INC -- $38,331.23 3,997 BRXYZ57
0.04% CGEM CULLINAN THERAPEUTICS INC -- $36,248.10 2,526 BM90J52
0.04% MNKD MANNKIND CORP -- $36,096.76 13,174 BF081J4
0.04% TBPH THERAVANCE BIOPHARMA INC -- $35,988.80 2,168 BMNDK09
0.04% ANNX ANNEXON INC -- $35,884.60 6,187 BMVV9R5
0.04% OMER OMEROS CORP -- $35,875.20 3,030 B4NB858
0.04% ABUS ARBUTUS BIOPHARMA CORP -- $35,770.05 8,223 BZ0QMB7
0.04% SPRY ARS PHARMACEUTICALS INC -- $34,415.92 4,228 BMCR7V2
0.04% KURA KURA ONCOLOGY INC -- $34,009.94 3,721 BYZD465
0.04% CTMX CYTOMX THERAPEUTICS INC -- $32,883.22 7,243 BYWVTY5
0.04% MESO MESOBLAST LTD- SPON ADR -- $32,682.57 2,237 BQS7491
0.04% ZLAB ZAI LAB LTD-ADR -- $32,149.44 1,464 BD9GVY0
0.04% ETON ETON PHARMACEUTICALS INC -- $31,052.40 1,145 BGL0JK3
0.04% CSTL CASTLE BIOSCIENCES INC -- $30,949.90 1,270 BKLCWZ3
0.04% BIOA BIOAGE LABS INC -- $30,770.49 1,857 BT9K6D8
0.04% DSGN DESIGN THERAPEUTICS INC -- $30,765.76 2,434 BMFK3H6
0.04% ARVN ARVINAS INC -- $30,096.00 2,736 BDZ30Q0
0.04% PSNL PERSONALIS INC -- $29,886.32 4,474 BJQ0608
0.03% PRME PRIME MEDICINE INC -- $28,556.60 7,718 BPBJFM7
0.03% VOR VOR BIOPHARMA INC -- $28,200.99 1,777 BRJJYT3
0.03% IRWD IRONWOOD PHARMACEUTICALS INC -- $28,110.32 6,958 B3MZ6K5
0.03% SLDB SOLID BIOSCIENCES INC -- $27,430.59 3,333 BQHN6C7
0.03% CRMD CORMEDIX INC -- $24,586.40 3,368 BJ0LT31
0.03% PRTA PROTHENA CORP PLC -- $24,403.00 2,300 B91XRN2
0.03% RIGL RIGEL PHARMACEUTICALS INC -- $24,390.03 777 BQD3J33
0.03% TECX TECTONIC THERAPEUTIC INC -- $24,079.80 804 BPBPCG8
0.03% UPB UPSTREAM BIO INC -- $23,885.40 2,310 BRCFFK6
0.03% ZVRA ZEVRA THERAPEUTICS INC -- $23,554.74 2,406 BLFBZ32
0.03% CMPS COMPASS PATHWAYS PLC -- $23,195.50 4,034 BMC3HS7
0.03% TRDA ENTRADA THERAPEUTICS INC -- $22,981.14 1,638 BP81RK8
0.03% KYTX KYVERNA THERAPEUTICS INC -- $22,857.12 2,442 BSMLR16
0.03% LRMR LARIMAR THERAPEUTICS INC -- $22,601.67 4,641 BMXNGZ6
0.03% FULC FULCRUM THERAPEUTICS INC -- $22,491.30 2,847 BJDX8Z9
0.03% ALLO ALLOGENE THERAPEUTICS INC -- $21,908.52 9,609 BFZNYB7
0.03% AQST AQUESTIVE THERAPEUTICS INC -- $21,642.25 5,215 BYVQJ96
0.03% LYEL LYELL IMMUNOPHARMA INC -- $21,243.33 909 BTNMG41
0.03% FDMT 4D MOLECULAR THERAPEUTICS IN -- $21,058.80 2,180 BKLXFX5
0.02% ESPR ESPERION THERAPEUTICS INC -- $20,951.00 10,220 BBNBTD2
0.02% LXEO LEXEO THERAPEUTICS INC -- $20,817.07 3,121 BQ6C357
0.02% KMDA KAMADA LTD -- $20,772.14 2,467 B2Q9833
0.02% MRVI MARAVAI LIFESCIENCES HLDGS-A -- $20,526.24 6,258 BMCWKZ2
0.02% PACB PACIFIC BIOSCIENCES OF CALIF -- $20,271.84 12,912 B4N8MH9
0.02% ABSI ABSCI CORP -- $20,251.35 6,429 BN94K69
0.02% ACRS ACLARIS THERAPEUTICS INC -- $20,207.60 5,155 BYV2W40
0.02% RGNX REGENXBIO INC -- $20,134.50 2,165 BZ0G875
0.02% AVIR ATEA PHARMACEUTICALS INC -- $19,366.20 3,339 BLN9Z50
0.02% AURA AURA BIOSCIENCES INC -- $19,249.35 2,715 BP81R42
0.02% IVVD INVIVYD INC -- $19,073.67 11,847 BM8NHS1
0.02% VNDA VANDA PHARMACEUTICALS INC -- $18,570.84 2,537 B12W3P6
0.02% GLPG GALAPAGOS NV-SPON ADR -- $18,309.92 634 B292NQ7
0.02% ENTA ENANTA PHARMACEUTICALS INC -- $18,170.46 1,242 B9L5200
0.02% ALT ALTIMMUNE INC -- $17,611.37 5,353 BFY7DC4
0.02% RCKT ROCKET PHARMACEUTICALS INC -- $16,896.88 4,642 BDFKQ07
0.02% CTNM CONTINEUM THERAPEUTICS INC-A -- $16,886.94 1,302 BPRBTY7
0.02% PBYI PUMA BIOTECHNOLOGY INC -- $16,457.18 2,174 B7F2TY6
0.02% CADL CANDEL THERAPEUTICS INC -- $15,942.60 3,126 BP0TQC5
0.02% KROS KEROS THERAPEUTICS INC -- $15,049.65 1,303 BM7V485
0.02% IMRX IMMUNEERING CORP - CLASS A -- $14,828.81 2,741 BMVBZF5
0.02% NMRA NEUMORA THERAPEUTICS INC -- $14,504.35 7,145 BN4JN37
0.02% EDIT EDITAS MEDICINE INC -- $14,149.86 4,174 BZ8FPH3
0.02% SIGA SIGA TECHNOLOGIES INC -- $14,028.54 3,063 2107437
0.02% NGNE NEUROGENE INC -- $13,743.12 662 BS2F741
0.02% ACIU AC IMMUNE SA -- $13,726.57 4,303 BZC0D70
0.02% CABA CABALETTA BIO INC -- $13,411.64 4,114 BK5MWR1
0.02% LENZ LENZ THERAPEUTICS INC -- $13,226.40 1,336 BQV0J03
0.02% AUTL AUTOLUS THERAPEUTICS PLC -- $12,693.96 8,577 BFMLGR4
0.01% AVXL ANAVEX LIFE SCIENCES CORP -- $12,364.56 3,963 BYTYP72
0.01% EOLS EVOLUS INC -- $12,298.80 2,770 BDRJH21
0.01% SLN SILENCE THERAPEUTICS PLC-ADR -- $12,282.84 2,007 BL5B6Z1
0.01% NBP NOVABRIDGE BIOSCIENCES -- $12,189.46 4,799 BKRRKY7
0.01% FHTX FOGHORN THERAPEUTICS INC -- $12,139.55 2,503 BMF7DT9
0.01% CCCC C4 THERAPEUTICS INC -- $11,514.72 4,172 BKX9NQ0
0.01% CHRS COHERUS ONCOLOGY INC -- $11,502.00 6,390 BRK0149
0.01% OBIO ORCHESTRA BIOMED HOLDINGS IN -- $10,887.14 2,414 BPRB2N7
0.01% ARCT ARCTURUS THERAPEUTICS HOLDIN -- $10,537.52 1,214 BKC9SX3
0.01% BCYC BICYCLE THERAPEUTICS PLC-ADR -- $10,018.80 1,980 BKDQKM6
0.01% VYGR VOYAGER THERAPEUTICS INC -- $9,928.80 2,520 BY7RB53
0.01% CDXS CODEXIS INC -- $9,150.57 3,861 B5LL2C2
0.01% OABI OMNIAB INC -- $8,984.84 6,154 BN13S71
0.01% MENS JYONG BIOTECH LTD -- $8,471.91 3,173 BPTK6Z2
0.01% CRBU CARIBOU BIOSCIENCES INC -- $8,469.40 3,995 BNYJR68
0.01% LFCR LIFECORE BIOMEDICAL INC -- $8,320.00 1,600 2517058
0.01% SGMT SAGIMET BIOSCIENCES INC-A -- $7,346.04 1,326 BP2NYN2
0.01% QSI QUANTUM-SI INC -- $7,024.88 8,355 BNR5QT9
0.01% TKNO ALPHA TEKNOVA INC -- $6,935.67 2,289 BP7L561
0.01% REPL REPLIMUNE GROUP INC -- $6,887.40 3,532 BDDVW37
0.01% TNYA TENAYA THERAPEUTICS INC -- $6,848.31 9,267 BNNXX52
0.01% BDTX BLACK DIAMOND THERAPEUTICS I -- $6,477.10 2,435 BKTV702
0.01% HUMA HUMACYTE INC -- $5,702.96 8,252 BMYTJP4
0.01% PEPG PEPGEN INC -- $4,970.29 2,941 BMTX3D7
0.01% PYXS PYXIS ONCOLOGY INC -- $4,527.10 2,663 BLBR8D5
0.01% AARD AARDVARK THERAPEUTICS INC -- $4,319.84 931 BTXQTX3
0.01% GOSS GOSSAMER BIO INC -- $4,270.68 9,895 BJ0CK86
-- RANI RANI THERAPEUTICS HOLDINGS-A -- $3,492.38 4,171 BNNXX18
-- STRO SUTRO BIOPHARMA INC -- $28.78 01 BTFHQP5
-- THRD THIRD HARMONIC BIO INC -- $00.00 1,662 BNNPQY8
-- 2324462D CARTESIAN THERAPEUTICS-CVR -- $00.00 9,785 BM9HFX3
37.29% -- NASDAQ BIO INDEX SWAP BNP PARIBAS 31,390,968 -- 5,174 --
29.78% -- NASDAQ BIOTECHNOLOGY INDEX SWAP CITIBANK NA 25,069,092 -- 4,132 --
26.68% -- NASDAQ BIOTECHNOLOGY INDEX SWAP BANK OF AMERICA NA 22,460,256 -- 3,702 --
19.02% -- NASDAQ BIOTECHNOLOGY INDEX SWAP GOLDMAN SACHS INTERNATIONAL 16,010,971 -- 2,639 --
17.30% -- NASDAQ BIOTECHNOLOGY INDEX SWAP SOCIETE GENERALE 14,560,944 -- 2,400 --
4.56% -- NASDAQ BIOTECHNOLOGY INDEX SWAP UBS AG 3,840,449 -- 633 --
-- -- NET OTHER ASSETS (LIABILITIES) -- $29,223,058.96 29,223,059 --

Index

as of 3/31/2026

  • Total Number of Companies256
  • Price/Book Ratio3.78
  • Dividend Yield ( % )0.85
  • Avg. Index Market Capitalization$6.50 billion
About the Index

The Nasdaq Biotechnology Index is designed to measure the performance of a set of Nasdaq-listed biotechnology and pharmaceutical companies.

Distributions

Ex-Dividend Date Record Date Payable Date Dividend Long-Term Capital Gain Short-Term Capital Gain Return of Capital
Get the latest perspectives and updates.

For the total return table above, since inception returns are cumulative for funds less than one year old; otherwise, returns are annualized. Market returns are based on the composite closing price and do not represent the returns you would receive if you traded shares at other times. The listing date is typically one or more days after the fund inception date. Therefore, NAV is used to calculate market returns prior to the listing date.

The expense ratio for certain funds includes a contractual fee waiver that results in a lower net expense ratio for some or all periods shown. For information about this ETF’s fees, please see above.

Holdings are subject to change. ProShares may invest in financial instruments (including derivatives) that, in combination, should have daily price return characteristics similar to the fund's benchmark.

Registered Investment Companies are required by the IRS to distribute substantially all of their income and capital gains to shareholders at least annually. For specific tax advice, we recommend you speak with a qualified tax professional.

This ProShares ETF seeks daily investment results that correspond, before fees and expenses, to 2x the daily performance of its underlying benchmark (the “Daily Target”). While the Fund has a daily investment objective, you may hold Fund shares for longer than one day if you believe it is consistent with your goals and risk tolerance. For any holding period other than a day, your return may be higher or lower than the Daily Target. These differences may be significant. Smaller index gains/losses and higher index volatility contribute to returns worse than the Daily Target. Larger index gains/losses and lower index volatility contribute to returns better than the Daily Target. The more extreme these factors are, the more they occur together, and the longer your holding period while these factors apply, the more your return will tend to deviate. Investors should consider periodically monitoring their geared fund investments in light of their goals and risk tolerance.

The performance quoted represents past performance and does not guarantee future results. Investment return and principal value of an investment will fluctuate so that an investor's shares, when sold or redeemed, may be worth more or less than the original cost. Shares are bought and sold at market price (not NAV) and are not individually redeemed from the fund. Market price returns are based upon the midpoint of the bid/ask spread at 4:00 p.m. ET (when NAV is normally determined for most funds) and do not represent the returns you would receive if you traded shares at other times. Your brokerage commissions will reduce returns. Current performance may be lower or higher than the performance quoted. For standardized returns and performance data current to the most recent month end, see above.

Index information does not reflect any management fees, transaction costs or expenses. Indexes are unmanaged, and one cannot invest directly in an index.

There is no guarantee that capital gain distributions will not be made in the future. There is no guarantee that dividends or interest income will be paid.

There is no guarantee any ProShares ETF will achieve its investment objective.

Shares of any ETF are generally bought and sold at market price (not NAV) and are not individually redeemed from the fund. Your brokerage commissions will reduce returns.

Investing involves risk, including the possible loss of principal. Leveraged ProShares ETFs are non-diversified and entail certain risks, including risk associated with the use of derivatives (swap agreements, futures contracts and similar instruments), imperfect benchmark correlation, leverage and market price variance, all of which can increase volatility and decrease performance. Please see their summary and full prospectuses for a more complete description of risks.

Technology companies may be subject to intense competition, product obsolescence, general economic conditions and government regulation and may have limited product lines, markets, financial resources or personnel.

The fund concentrates its investments in certain sectors. Narrowly focused investments typically exhibit higher volatility.

Carefully consider the investment objectives, risks, charges and expenses of ProShares before investing. This and other information can be found in their summary and full prospectuses. Read them carefully before investing.

The "Nasdaq Biotechnology Index®" is a trademark of The Nasdaq OMX Group, Inc. ("Nasdaq OMX") and has been licensed for use by ProShares. ProShares have not been passed on by Nasdaq OMX or its subsidiaries or affiliates as to their legality or suitability. ProShares based on the Nasdaq Biotechnology Index are not sponsored, endorsed, sold or promoted by Nasdaq OMX or its subsidiaries or affiliates, and they make no representation regarding the advisability of investing in ProShares. THIS ENTITY AND ITS AFFILIATES MAKE NO WARRANTIES AND BEAR NO LIABILITY WITH RESPECT TO PROSHARES.

Quote data provided by Interactive Data - Real Time Services, Inc. and subject to terms of use.

ProShares are distributed by SEI Investments Distribution Co., which is not affiliated with the funds’ advisor or sponsor.

Your use of this site signifies that you accept our Terms and Conditions of Use.